---
title: "China is 46% of Axcelis's quarterly revenue and holds the last approval on its $4.4 billion Veeco merger"
description: "Axcelis printed its best bookings since late 2023 and guided fourth-quarter revenue to $275 million. Beijing's antitrust regulator now holds the deal's only remaining approval, with closing pushed to the first quarter of 2027."
publisher: "The Inference"
section: "Chips"
published: 2026-11-08T17:00:28.919Z
modified: 2026-11-08T17:00:28.919Z
canonical: https://theinference.org/article/china-is-46-of-axcelis-s-quarterly-revenue-and-holds-the-last-approval-on-its-4-4-billion-veeco-merger
language: en
keywords: "Chips, Semiconductors, Mergers & Acquisitions, China, Earnings"
---

# China is 46% of Axcelis's quarterly revenue and holds the last approval on its $4.4 billion Veeco merger

> Axcelis printed its best bookings since late 2023 and guided fourth-quarter revenue to $275 million. Beijing's antitrust regulator now holds the deal's only remaining approval, with closing pushed to the first quarter of 2027.

[Axcelis Technologies](https://theinference.org/markets/companies/axcelis-technologies), the Massachusetts maker of ion-implantation machines for chip factories, earned a demand recovery this quarter, then handed the timing of the payoff to Beijing. Third-quarter bookings jumped by half to $222 million, the strongest since late 2023 [1]. The backlog exited the quarter at $531 million [1].

The number that matters more came from interim finance chief [David Ryzhik](https://theinference.org/markets/people/david-ryzhik) on the earnings call: China was 46% of quarterly revenue, with system bookings close behind [2]. The company's [10-Q](https://www.marketscreener.com/news/axcelis-technologies-quarterly-report-for-quarter-ending-september-30-2026-form-10-q-ce785fdddc8bf62c), the quarterly report it files with the US Securities and Exchange Commission, says antitrust clearance from China's regulator, SAMR, is the only approval still outstanding on its [$4.4 billion all-stock purchase of Veeco Instruments](https://theinference.org/article/axcelis-veeco-merger-slips-to-q1-2027-with-a-veeco-tool-stuck-at-us-customs), the Nasdaq-listed chip-equipment maker [3][4][5].

## The AI buildout has reached the implant step

The demand is real, and the chain runs forward from the data center. AI facilities need power conversion from the grid to the rack, plus dense supporting chips; such mature-node devices took 78% of Axcelis's own system shipments this quarter [6]. Every chip starts on a wafer that passes through ion implantation, the step that fires dopants into silicon to set its electrical properties, and implanters are all Axcelis has sold for more than four decades [4].

Chief executive [Russell Low](https://theinference.org/markets/people/russell-low) [tied the North American bookings jump to data-center spillover](https://finance.yahoo.com/markets/stocks/articles/axcelis-technologies-inc-acls-q3-031336854.html), power bookings have risen four straight quarters, and 2026 will be Axcelis's best year for DRAM, the workhorse memory chips, topping its $90 million record [2].

*Chart: **Q4 guidance would be Axcelis's biggest revenue quarter since the end of 2023** Column chart of Axcelis quarterly revenue from Q4 2023 through Q3 2026 plus the guided fourth quarter of 2026 at $275 million, showing the 2024 to 2025 downturn and a recovery that would still sit below the 2023 peak.*

*Quarterly revenue in millions of US dollars from Axcelis SEC filings; the final bar is company guidance for Q4 2026, marked as an estimate. [2][7][9]*

## The beat underneath is thinner than the headline

Non-GAAP gross margin printed at 41.2% against a 43% outlook, cut by a sharply stronger Korean won [1]. About $0.30 of the $0.45 GAAP earnings beat came from tax-audit items rather than the factory floor, which is why the fourth-quarter GAAP guide of $1.15 sits below the $1.21 just reported [4][7]. Nine-month operating cash flow fell to $77 million from $125 million a year earlier, with about $20 million of [Veeco](https://theinference.org/markets/companies/veeco) deal costs inside the accounts [3][4].

*Chart: **Operating cash flow has thinned out during the merger** Line chart of Axcelis quarterly operating cash flow from Q4 2023 through Q3 2026, showing a drop from about $45 million a quarter through 2024 and 2025 to the high teens in the first half of 2026, with one negative quarter in Q4 2025.*

*Quarterly operating cash flow in millions of US dollars from Axcelis SEC filings; the nine months to Q3 2026 total $77 million against $125 million a year earlier, with about $20 million of Veeco deal costs inside the accounts. [9]*

## One regulator now decides both stories

If SAMR clears, [each Veeco share converts into a fixed 0.3575 Axcelis shares](https://finance.yahoo.com/markets/stocks/articles/axcelis-technologies-veeco-instruments-expected-130000825.html) [5]. Axcelis holders would own about 58% of a company that adds Veeco's laser annealing, advanced packaging and other process lines: revenue not tied to one step and one geography [4].

If SAMR refuses, Veeco holders keep their company, while Axcelis holders [keep $615 million of cash and the backlog](https://www.vlsi.kr/en/axcelis-q3-2026-flash-en/) but no second engine [1]. Low told analysts China is developing its own domestic implant supply, which turns the concentration from geographic to strategic [2]. B. Riley [cut its target to $140 from $165](https://www.marketscreener.com/news/b-riley-adjusts-axcelis-technologies-price-target-to-140-from-165-maintains-buy-rating-ce785fd2d88bf022) on November 6 and kept its buy rating [8]. The shares closed at $99.24 [8].

Half the revenue and the whole merger sit in the same pair of hands. Three things decide what happens next: SAMR's ruling [3], the fresh US antitrust submission the companies plan to make once their current clearance lapses [5], and [whether the guided $275 million fourth quarter holds its roughly 42.5% margin against the won](https://seekingalpha.com/news/4667628-axcelis-expects-about-275m-q4-revenue-as-it-targets-veeco-merger-close-by-end-of-q1-2027) [1].

## Takeaway

Axcelis's recovery is real, but Beijing's SAMR now holds the last approval on the $4.4 billion Veeco merger and 46% of the revenue, so one regulator decides both stories.

## Sources

1. [Seeking Alpha, 'Axcelis expects about $275M Q4 revenue as it targets Veeco merger close by end of Q1 2027', 5 November 2026](https://seekingalpha.com/news/4667628-axcelis-expects-about-275m-q4-revenue-as-it-targets-veeco-merger-close-by-end-of-q1-2027)
2. [GuruFocus via Yahoo Finance, 'Axcelis Technologies Inc (ACLS) (Q3 2026) Earnings Call Highlights', 5 November 2026](https://finance.yahoo.com/markets/stocks/articles/axcelis-technologies-inc-acls-q3-031336854.html)
3. [MarketScreener, 'Axcelis Technologies: Quarterly Report for Quarter Ending September 30, 2026 (Form 10-Q)', 5 November 2026](https://www.marketscreener.com/news/axcelis-technologies-quarterly-report-for-quarter-ending-september-30-2026-form-10-q-ce785fdddc8bf62c)
4. [VLSI Korea, 'Axcelis Q3 Revenue of $237.8 Million Clears Its Guide, With a Tax Item Inside the EPS Beat', 6 November 2026](https://www.vlsi.kr/en/axcelis-q3-2026-flash-en/)
5. [PR Newswire via Yahoo Finance, 'Axcelis Technologies and Veeco Instruments Provide Update on Expected Timing of Merger Closing', 2 November 2026](https://finance.yahoo.com/markets/stocks/articles/axcelis-technologies-veeco-instruments-expected-130000825.html)
6. [AInvest, 'Axcelis Technologies: Memory Growth Claims Shift from General Outlook to Phased Capacity', 6 November 2026](https://www.ainvest.com/news/axcelis-technologies-memory-growth-claims-shift-general-outlook-phased-capacity-2611/)
7. [Axcelis Technologies press release, 'Axcelis Announces Financial Results for Third Quarter 2026', 5 November 2026](https://investor.axcelis.com/news-releases/news-release-details/axcelis-announces-financial-results-third-quarter-2026/)
8. [MT Newswires via MarketScreener, 'B. Riley Adjusts Axcelis Technologies Price Target to $140 From $165, Maintains Buy Rating', 6 November 2026](https://www.marketscreener.com/news/b-riley-adjusts-axcelis-technologies-price-target-to-140-from-165-maintains-buy-rating-ce785fd2d88bf022)
9. [Axcelis Technologies, quarterly figures from its SEC filings, retrieved 8 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001113232)


---

China is 46% of Axcelis's quarterly revenue and holds the last approval on its $4.4 billion Veeco merger — The Inference. Canonical: https://theinference.org/article/china-is-46-of-axcelis-s-quarterly-revenue-and-holds-the-last-approval-on-its-4-4-billion-veeco-merger